Fungal allergens

Area of Science:

• Allergen immunotherapy
• Respiratory immunology
• Medical mycology

Background:

• Airborne fungal spores are prevalent, often exceeding pollen concentrations, and act as potent allergens.
• Fungal allergens trigger type I hypersensitivity reactions, leading to allergic rhinitis and asthma in sensitized individuals.
• The exact prevalence of fungal allergy is uncertain, affecting a significant portion of atopic individuals and the general population.

Purpose of the Study:

• To review recent progress in the isolation and characterization of fungal allergens.
• To highlight the importance of well-characterized fungal extracts for accurate diagnosis and effective immunotherapy.
• To discuss the challenges in producing standardized fungal extracts due to their complex and variable nature.

Main Methods:

• Review of scientific literature on fungal allergens and allergy.
• Summary of progress in isolating and characterizing specific fungal allergens.
• Discussion of purification of allergens from various fungal genera.

Main Results:

• Significant progress has been made in identifying and characterizing key allergens from genera like Alternaria, Aspergillus, and Cladosporium.
• Allergens from other genera, including basidiomycetes, have also been successfully purified.
• Characterized fungal allergens are becoming available, moving away from crude, non-standardized extracts.

Conclusions:

• Availability of characterized fungal allergens is crucial for advancing research on fungal allergy prevalence and immunotherapy effectiveness.
• Improved diagnostic and therapeutic strategies for fungal allergy are anticipated due to these advancements.
• Standardized fungal extracts will enhance the precision and reliability of diagnosing and treating fungal allergies.